IL139827D0 - BENZIMIDAZOLE ANALOGS AS DOWN-REGULATORS OF IgE - Google Patents

BENZIMIDAZOLE ANALOGS AS DOWN-REGULATORS OF IgE

Info

Publication number
IL139827D0
IL139827D0 IL13982799A IL13982799A IL139827D0 IL 139827 D0 IL139827 D0 IL 139827D0 IL 13982799 A IL13982799 A IL 13982799A IL 13982799 A IL13982799 A IL 13982799A IL 139827 D0 IL139827 D0 IL 139827D0
Authority
IL
Israel
Prior art keywords
ige
regulators
down
benzimidazole analogs
benzimidazole
Prior art date
Application number
IL13982799A
Original Assignee
Avanir Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US8649498P priority Critical
Application filed by Avanir Pharmaceuticals filed Critical Avanir Pharmaceuticals
Priority to PCT/US1999/011490 priority patent/WO1999061020A1/en
Publication of IL139827D0 publication Critical patent/IL139827D0/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22198947&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL139827(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

Links

IL13982799A 1998-05-22 1999-05-21 BENZIMIDAZOLE ANALOGS AS DOWN-REGULATORS OF IgE IL139827D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US8649498P true 1998-05-22 1998-05-22
PCT/US1999/011490 WO1999061020A1 (en) 1998-05-22 1999-05-21 BENZIMIDAZOLE ANALOGS AS DOWN-REGULATORS OF IgE

Publications (1)

Publication Number Publication Date
IL139827D0 true IL139827D0 (en) 2002-02-10

Family

ID=22198947

Family Applications (3)

Application Number Title Priority Date Filing Date
IL13982699A IL139826D0 (en) 1998-05-22 1999-05-21 BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF IgE
IL13982799A IL139827D0 (en) 1998-05-22 1999-05-21 BENZIMIDAZOLE ANALOGS AS DOWN-REGULATORS OF IgE
IL13982899A IL139828D0 (en) 1998-05-22 1999-05-21 COMPOUNDS HAVING IgE AFFECTING PROPERTIES

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL13982699A IL139826D0 (en) 1998-05-22 1999-05-21 BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF IgE

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL13982899A IL139828D0 (en) 1998-05-22 1999-05-21 COMPOUNDS HAVING IgE AFFECTING PROPERTIES

Country Status (21)

Country Link
US (2) US6271390B1 (en)
EP (3) EP1077700B1 (en)
JP (3) JP2002516276A (en)
CN (4) CN1311675A (en)
AT (1) AT292465T (en)
AU (3) AU4197899A (en)
BR (3) BR9910642A (en)
CA (3) CA2332985A1 (en)
CZ (2) CZ20004350A3 (en)
DE (1) DE69924607T2 (en)
ES (1) ES2241285T3 (en)
HU (3) HU0102550A3 (en)
IL (3) IL139826D0 (en)
MX (3) MXPA00011467A (en)
NO (3) NO20005888L (en)
NZ (2) NZ508413A (en)
PL (3) PL345952A1 (en)
RU (2) RU2236220C2 (en)
UA (2) UA67775C2 (en)
WO (3) WO1999061019A1 (en)
ZA (3) ZA200007754B (en)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070208087A1 (en) 2001-11-02 2007-09-06 Sanders Virginia J Compounds, compositions and methods for the treatment of inflammatory diseases
US6911462B2 (en) * 1998-05-22 2005-06-28 Avanir Pharmaceuticals Benzimidazole compounds for regulating IgE
US6759425B2 (en) 1999-10-21 2004-07-06 Avanir Pharmaceuticals Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
EP1077700B1 (en) * 1998-05-22 2005-04-06 Avanir Pharmaceuticals BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF IgE
US6919366B2 (en) * 1998-05-22 2005-07-19 Avanir Pharmaceuticals Benzimidazole derivatives as modulators of IgE
WO2000015603A1 (en) 1998-09-11 2000-03-23 Ajinomoto Co., Inc. Benzene derivatives and medicinal use thereof
US6270746B1 (en) * 1999-02-17 2001-08-07 David H. Katz Assay for the identification of IgE antibody suppressors
CA2368631A1 (en) * 1999-03-26 2000-10-05 Purdue Pharma, Ltd. Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
CN1372548A (en) 1999-07-01 2002-10-02 味之素株式会社 Heterocyclic compounds and medicinal use thereof
WO2001016091A1 (en) 1999-09-01 2001-03-08 Ajinomoto Co.,Inc. Biscyclopropanecarboxylic acid amide compounds and medicinal use thereof
RU2003127367A (en) * 2001-03-12 2005-03-20 Аванир Фармасьютиклз (Us) Benzimidazole compounds for ige modulation and inhibition of cell proliferation
US6448281B1 (en) 2000-07-06 2002-09-10 Boehringer Ingelheim (Canada) Ltd. Viral polymerase inhibitors
EP1482928B1 (en) * 2001-07-27 2009-09-23 Curis, Inc. Mediators of hedgehog signaling pathways,compositions and uses related thereto
EP1435947B1 (en) 2001-10-19 2007-08-15 Ortho-McNeil Pharmaceutical, Inc. 2-phenyl benzimidazoles and imidazo-¬4,5|-pyridines as cds1/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer
US20080081788A1 (en) * 2002-01-14 2008-04-03 Lipps Binie V Diagnosis and treatment for immunoglobulin E (IgE) implicated disorders
US20030157555A1 (en) * 2002-01-14 2003-08-21 Lipps Binie V. Diagnosis and treatment for immunoglobulin E ( IgE) implicated disorders
TW200304820A (en) * 2002-03-25 2003-10-16 Avanir Pharmaceuticals Use of benzimidazole analogs in the treatment of cell proliferation
AU2003249678B2 (en) 2002-05-31 2009-03-19 Protamed, Inc. Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes, and Parkinson's disease
EP1388535A1 (en) 2002-08-07 2004-02-11 Aventis Pharma Deutschland GmbH Acylated arylcycloalkylamines and their use as pharmaceuticals
WO2004016750A2 (en) 2002-08-14 2004-02-26 Macrogenics, Inc. FcϜRIIB-SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF
AU2003270426A1 (en) 2002-09-12 2004-04-30 Avanir Pharmaceuticals PHENYL-INDOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION
TWI276631B (en) 2002-09-12 2007-03-21 Avanir Pharmaceuticals Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
WO2004041280A1 (en) * 2002-11-02 2004-05-21 Kyung-Lim Lee Composition for preventing secretion of immunoglobulin e-dependent histamine releasing factor
GB2397301A (en) * 2003-01-14 2004-07-21 Novo Pharmaceuticals Ltd De Substituted 1,3,5-triazine derivatives
US7132440B2 (en) 2003-04-17 2006-11-07 Janssen Pharmaceutica, N.V. Substituted benzimidazoles and imidazo-[4,5]-pyridines
US20050256179A1 (en) * 2003-08-08 2005-11-17 Sircar Jagadish C Selective pharmacologic inhibition of protein trafficking and related methods of treating human diseases
EP1751097B1 (en) * 2004-05-12 2009-12-30 Proteotech, Inc. Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies
WO2006004791A1 (en) 2004-06-30 2006-01-12 Janssen Pharmaceutica, N.V. Aryl-substituted benzimidazole and imidazopyridine ethers as anti-cancer agents
WO2006040645A1 (en) * 2004-10-11 2006-04-20 Ranbaxy Laboratories Limited N-(3,5-dichloropyridin-4-yl)-2,4,5-alkoxy and 2,3,4-alkoxy benzamide derivatives as pde-iv (phophodiesterase type-iv) inhibitors for the treatment of inflammatory diseases such as asthma
EP1954287B2 (en) 2005-10-31 2016-02-24 Merck Sharp & Dohme Corp. Cetp inhibitors
EP1790345A1 (en) * 2005-11-02 2007-05-30 Esbatech AG Triazin beta-secretase inhibitors
US7671221B2 (en) * 2005-12-28 2010-03-02 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
JP5165586B2 (en) * 2005-12-28 2013-03-21 バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated 1- (Benzo [d] [1,3] dioxol-5-yl) -N- (phenyl) cyclopropane-carboxamide derivatives and related as modulators of ATP binding cassette transporters for the treatment of cystic fibrosis Compound
ES2599319T3 (en) 2006-06-26 2017-02-01 Macrogenics, Inc. Fc RIIB specific antibodies and their methods of use
WO2010075376A2 (en) 2008-12-23 2010-07-01 Abbott Laboratories Anti-viral compounds
RU2505539C2 (en) 2008-12-23 2014-01-27 Эбботт Лэборетриз Antiviral compounds
US9278922B2 (en) 2009-04-15 2016-03-08 Abbvie Inc. Anti-viral compounds
US9394279B2 (en) 2009-06-11 2016-07-19 Abbvie Inc. Anti-viral compounds
NZ605440A (en) 2010-06-10 2014-05-30 Abbvie Bahamas Ltd Solid compositions comprising an hcv inhibitor
US8937150B2 (en) 2009-06-11 2015-01-20 Abbvie Inc. Anti-viral compounds
SG10201702522UA (en) 2009-06-11 2017-05-30 Abbvie Bahamas Ltd Anti-viral compounds to treat hcv infection
US8716454B2 (en) 2009-06-11 2014-05-06 Abbvie Inc. Solid compositions
US8420655B2 (en) 2009-12-04 2013-04-16 Boehringer Ingelheim International Gmbh Benzimidazole inhibitors of leukotriene production
US9321735B2 (en) * 2010-07-20 2016-04-26 Vestaron Corporation Insecticidal triazines and pyrimidines
EP2632915B1 (en) 2010-10-29 2015-08-12 Boehringer Ingelheim International GmbH Benzimidazole inhibitors of leukotriene production
US8772304B2 (en) 2010-11-01 2014-07-08 Boehringer Ingelheim International Gmbh Benzimidazole inhibitors of leukotriene production
US10201584B1 (en) 2011-05-17 2019-02-12 Abbvie Inc. Compositions and methods for treating HCV
US9034832B2 (en) 2011-12-29 2015-05-19 Abbvie Inc. Solid compositions
EP3089757A1 (en) 2014-01-03 2016-11-09 AbbVie Inc. Solid antiviral dosage forms

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3017610A (en) * 1957-03-15 1962-01-16 Curtiss Wright Corp Electronic data file processor
US4939133A (en) * 1985-10-01 1990-07-03 Warner-Lambert Company N-substituted-2-hydroxy-α-oxo-benzeneacetamides and pharmaceutical compositions having activity as modulators of the arachidonic acid cascade
LU86258A1 (en) * 1986-01-21 1987-09-03 Rech Dermatologiques C I R D S Aromatic benzamido compounds, their method of preparing and their use in human or veterinary medicine and in cosmetics
US4744026A (en) * 1986-04-11 1988-05-10 American Telephone And Telegraph Company, At&T Bell Laboratories Methods and apparatus for efficient resource allocation
IT1232252B (en) * 1989-02-22 1992-01-28 Rotta Research Lab Derivatives of n phenyl benzamide to attivita 'antiulcer and antiallerica and process for their preparation
DE59010069D1 (en) * 1989-11-21 1996-02-29 Bayer Ag Coumarin derivatives, processes for their preparation, their use and thiazolyl-acetic acid derivatives as intermediates
DE69113162D1 (en) 1990-08-02 1995-10-26 Hoffmann La Roche Anti Allergic mixture.
IE71647B1 (en) 1991-01-28 1997-02-26 Rhone Poulenc Rorer Ltd Benzamide derivatives
DE69309030T2 (en) 1992-06-15 1997-09-25 Celltech Therapeutics Ltd Trisubstituted phenyl as selective phosphodiesterase IV inhibitors
US5521813A (en) * 1993-01-15 1996-05-28 Strategic Weather Services System and method for the advanced prediction of weather impact on managerial planning applications
US5496826A (en) 1994-09-02 1996-03-05 Bristol-Myers Squibb Company Pharmaceutical methods of using heterocyclic derivatives of N-phenylamides
US5821258A (en) * 1994-12-27 1998-10-13 Mitsui Chemicals, Inc. Phenylbenzimidazole derivatives
WO1998017267A1 (en) * 1996-10-23 1998-04-30 Zymogenetics, Inc. Compositions and methods for treating bone deficit conditions
US6988076B2 (en) * 1997-05-21 2006-01-17 Khimetrics, Inc. Strategic planning and optimization system
EP1077700B1 (en) * 1998-05-22 2005-04-06 Avanir Pharmaceuticals BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF IgE
US6910017B1 (en) * 1999-03-05 2005-06-21 Profitlogic, Inc. Inventory and price decision support
US6405175B1 (en) * 1999-07-27 2002-06-11 David Way Ng Shopping scouts web site for rewarding customer referrals on product and price information with rewards scaled by the number of shoppers using the information
US6546387B1 (en) * 1999-11-15 2003-04-08 Transcom Software Inc. Computer network information management system and method using intelligent software agents
US20020042739A1 (en) * 2000-03-13 2002-04-11 Kannan Srinivasan Method and system for creating and administering internet marketing promotions
US20020023001A1 (en) * 2000-07-11 2002-02-21 Mcfarlin James A. Method and apparatus for online creation and sale of custom local store marketing materials
AU1979102A (en) * 2000-11-15 2002-05-27 Manugistics Atlanta Inc Promotion pricing system and method
US20020198794A1 (en) * 2001-06-21 2002-12-26 Williams Edward P. Inventory management system for determining suggested part stocking levels for a vehicle dealer

Also Published As

Publication number Publication date
DE69924607T2 (en) 2006-02-02
CA2332985A1 (en) 1999-12-02
JP2002516277A (en) 2002-06-04
NO20005888L (en) 2001-01-22
AT292465T (en) 2005-04-15
ES2241285T3 (en) 2005-10-16
PL345560A1 (en) 2001-12-17
ZA200007752B (en) 2001-12-05
AU754943B2 (en) 2002-11-28
ZA200007753B (en) 2001-07-18
JP2002516276A (en) 2002-06-04
NO20005887D0 (en) 2000-11-21
UA67774C2 (en) 2001-03-15
JP2002516274A (en) 2002-06-04
EP1077700B1 (en) 2005-04-06
UA67775C2 (en) 2001-03-15
MXPA00011422A (en) 2002-12-13
RU2236220C2 (en) 2004-09-20
ZA200007754B (en) 2001-08-16
HU0102550A2 (en) 2001-10-28
MXPA00011467A (en) 2002-10-17
HU0101894A2 (en) 2002-02-28
WO1999061013A2 (en) 1999-12-02
US6271390B1 (en) 2001-08-07
BR9910641A (en) 2001-10-02
AU4197899A (en) 1999-12-13
HU0102128A2 (en) 2002-03-28
PL345219A1 (en) 2001-12-03
CA2332999A1 (en) 1999-12-02
CA2332989A1 (en) 1999-12-02
CN1311679A (en) 2001-09-05
NO20005888D0 (en) 2000-11-21
HU0102128A3 (en) 2002-05-28
AU754562B2 (en) 2002-11-21
CN1219510C (en) 2005-09-21
US20020010343A1 (en) 2002-01-24
MXPA00011470A (en) 2002-10-17
CN1721411A (en) 2006-01-18
NZ508416A (en) 2004-01-30
BR9910642A (en) 2001-10-09
HU0101894A3 (en) 2002-07-29
IL139826D0 (en) 2002-02-10
NZ508413A (en) 2003-08-29
BR9910640A (en) 2001-10-30
CZ20004351A3 (en) 2001-10-17
EP1077695A2 (en) 2001-02-28
EP1077700A1 (en) 2001-02-28
WO1999061013A3 (en) 2000-04-06
WO1999061020A1 (en) 1999-12-02
WO1999061019A1 (en) 1999-12-02
NO20005889L (en) 2001-01-22
CN1317965A (en) 2001-10-17
IL139828D0 (en) 2002-02-10
HU0102550A3 (en) 2002-11-28
AU4094299A (en) 1999-12-13
CZ20004350A3 (en) 2002-02-13
CN1311675A (en) 2001-09-05
NO20005887L (en) 2001-01-19
EP1079830A1 (en) 2001-03-07
RU2236221C2 (en) 2004-09-20
NO20005889D0 (en) 2000-11-21
AU4312099A (en) 1999-12-13
PL345952A1 (en) 2002-01-14
US6451829B2 (en) 2002-09-17
DE69924607D1 (en) 2005-05-12

Similar Documents

Publication Publication Date Title
DE69914370D1 (en) Determination of facial lower areas
DK1049695T3 (en) 2-Phenyl-substituted imidazotriazinones as phosphodiesterase inhibitors
GB2337461B (en) Formulation
DE59803292D1 (en) Triazolic compounds and their use as dopamin-d 3-ligands
DE69838172D1 (en) Oxindolylchinazole derivatives as angiogenesehemmer
DE69821985D1 (en) Ortho-anthranilamid derivatives as anticoagulanties
DK1107940T3 (en) Vitamin D3 mimic compounds
DE69915004D1 (en) 5-Oxo-pyrrolidine-2-carboxylic acid Hydroxamidderivate
DE69927802D1 (en) Preparation of organic acids
DE69939382D1 (en) Transdermalally applied tolterodin as antimuscarin aggregate for the treatment of the hyperactive bubble
DE69923849D1 (en) Quinolin-2-on derivatives use as anticrophosis
DE69928414D1 (en) 4-aminopyrrolopyrimidine as kinaseinhibitors
DE69824199D1 (en) Lactam compounds as metalloprotease inhibitors
DK1121111T3 (en) Compounds for the treatment of weight loss
DE69930518D1 (en) Alkinyl-substituted chinolin-2-on derivatives used as anticrogen agents
DK1634498T3 (en) Exo-S-mecamylamine formulation
DE69906492D1 (en) Fluorine amino acid derivatives
DE69942694D1 (en) Of the
DE69928655D1 (en) Substituted porphyrine
PL334997A1 (en) Derivatives or arylosulphonyl-hydroxamic acid
AT513816T (en) Intermediate products for the manufacture of certain triazolopyrimidines as p2t antagonists
DE69926981D1 (en) Method of sterilization using small amounts of sterilant to determine the loading
RU2001101433A (en) β-CARBOLINE COMPOUNDS
PL347384A1 (en) Substituted benzopyran analogs for the treatment of inflammation
DE69813616D1 (en) Cyclohexencarboxylate as inhibitors of the neuraminidase